First trial targeting mutation, **t cancer type, gives mixed results
 

First trial targeting mutation, **t cancer type, gives mixed results
(Reuters Health) - A powerful skin cancer drug may also be effective against lung cancer and other types of malignancies, according to a **vel study that focused on a gene mutation seen in many kinds of tumors.
http://i0.wp.com/reuters.us.feedspor...f?resize=1%2C1http://feeds.feedburner.com/~ff/reut...?d=yIl2AUoC8zA http://feeds.feedburner.com/~ff/reut...ds:F7zBnMyn0Lo http://feeds.feedburner.com/~ff/reut...ds:V_sGLiPBpWU
http://feeds.feedburner.com/~r/reute...~4/Mf_wctv_KYU